Aktive Positionen von David Hyman
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| LOXO ONCOLOGY INC | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2020 | - |
| ELI LILLY AND COMPANY | Technik-/Wissenschafts-/F&E-Leiter | 16.10.2023 | - |
Karriereverlauf von David Hyman
Statistik
International
| Vereinigte Staaten | 3 |
Operativ
| Chief Tech/Sci/R&D Officer | 2 |
Sektoral
| Health Technology | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ELI LILLY AND COMPANY | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Loxo Oncology, Inc.
 Loxo Oncology, Inc. Pharmaceuticals: MajorHealth Technology Loxo Oncology, Inc. is a biopharmaceutical company, which engages in the development of small molecule therapeutics for the treatment of cancer. It focuses on genetic alterations, targeted therapies, and genetic testing. The company was founded by Joshua H. Bilenker in May 2013 and is headquartered in Stamford, CT. | Health Technology |
- Börse
- Insiders
- David Hyman
- Erfahrung
